A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)

Launched by ABBOTT · Aug 30, 2001

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• Concurrent Medication:
• Allowed:
• • All drugs used for the standard treatment of Pneumocystis carinii pneumonia (PCP).
• • Other drugs for treatment of other AIDS conditions if they have been started more than 3 months prior to study entry.
• Patients must have:
• • Diagnosis of AIDS.
• • Weight loss \> 10 percent of premorbid body weight.
• • First or second episode of acute Pneumocystis carinii pneumonia (PCP).
• • Exclusion Criteria
• Co-existing Condition:
• Patients with the following conditions or symptoms are excluded:
• • Do Not Resuscitate (DNR) status.
• • Biliary stasis.
• Patients with the following are excluded:
• • Do Not Resuscitate (DNR) status.
• • Biliary stasis.
• Prior Medication:
• Excluded within 3 months of study entry:
• • Immunomodulators.
• • Antiviral new DT